Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes

Nature Methods

Volumn 10, Issue 8, 2013, Pages 781-787

  Nunes, Sara S ^a,b   Miklas, Jason W ^a   Liu, Jie ^c   Aschar Sobbi, Roozbeh ^c   Xiao, Yun ^a   Zhang, Boyang ^a   Jiang, Jiahua ^d   Massé, Stéphane ^e   Gagliardi, Mark ^f   Hsieh, Anne ^a   Thavandiran, Nimalan ^a   Laflamme, Michael A ^g   Nanthakumar, Kumaraswamy ^e   Gross, Gil J ^c,d,h,i   Backx, Peter H ^c,f,i   Keller, Gordon ^f   Radisic, Milica ^a,c,i  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g UNIVERSITY OF WASHINGTON   (United States)

^h HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

ⁱ HEART AND STROKE FOUNDATION OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION;

ARTICLE; BIOENGINEERING; CALCIUM TRANSPORT; CELL MATURATION; CONTROLLED STUDY; ELECTROSTIMULATION; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MUSCLE FIBRIL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; TISSUE STRUCTURE;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; ELECTRIC STIMULATION; ELECTROPHYSIOLOGICAL PHENOMENA; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCARDIUM; MYOCYTES, CARDIAC; TISSUE ENGINEERING;

EID: 84881480907     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.2524     Document Type: Article

References (44)

1. Kehat, I. et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-414 (2001). (Pubitemid 32730787)
2. Yang, L. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524-528 (2008). (Pubitemid 351733312)
3. Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-e41 (2009).
4. Kattman, S.J. et al. Stage-specifc optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240 (2011).
5. Carvajal-Vergara, X. et al. Patient-specifc induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808-812 (2010).
6. Lafamme, M.A. & Murry, C.E. Heart regeneration. Nature 473, 326-335 (2011).
7. Snir, M. et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 285, H2355-H2363 (2003). (Pubitemid 37443051)
8. McDevitt, T.C., Lafamme, M.A. & Murry, C.E. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J. Mol. Cell Cardiol. 39, 865-873 (2005). (Pubitemid 41572319)
9. Mummery, C. et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733-2740 (2003). (Pubitemid 36667249)
10. 2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 24, 236-245 (2006). (Pubitemid 44464791)
11. Doss, M.X. et al. Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS ONE 7, e40288 (2012).
12. Liu, J., Fu, J.D., Siu, C.W. & Li, R.A. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25, 3038-3044 (2007). (Pubitemid 350294429)
13. Satin, J. et al. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 26, 1961-1972 (2008).
14. Tulloch, N.L. et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 109, 47-59 (2011).
15. Caspi, O. et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100, 263-272 (2007). (Pubitemid 46208727)
16. Chien, K.R., Knowlton, K.U., Zhu, H. & Chien, S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 5, 3037-3046 (1991). (Pubitemid 21892863)
17. Frank, D. et al. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specifc gene program. Hypertension 51, 309-318 (2008). (Pubitemid 351159944)
18. Kuwahara, K. et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22, 6310-6321 (2003). (Pubitemid 37522588)
19. Nuccitelli, R. Endogenous ionic currents and DC electric felds in multicellular animal tissues. Bioelectromagnetics 1 (suppl.), 147-157 (1992).
20. Henderson, D.J. & Chaudhry, B. Getting to the heart of planar cell polarity signaling. Birth Defects Res. A Clin. Mol. Teratol. 91, 460-467 (2011).
21. Zhao, M., Forrester, J. & McCaig, C. A small, physiological electric feld orients cell division. Proc. Natl. Acad. Sci. USA 96, 4942-4946 (1999). (Pubitemid 29214515)
22. Radisic, M. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. USA 101, 18129-18134 (2004). (Pubitemid 40054085)
23. Berger, H.J. et al. Continual electric feld stimulation preserves contractile function of adult ventricular myocytes in primary culture. Am. J. Physiol. 266, H341-H349 (1994). (Pubitemid 2045790)
24. Borg, T.K. et al. Specialization at the Z line of cardiac myocytes. Cardiovasc. Res. 46, 277-285 (2000). (Pubitemid 30204600)
25. Bird, S.D. et al. The human adult cardiomyocyte phenotype. Cardiovasc. Res. 58, 423-434 (2003). (Pubitemid 36570400)
26. Frey, N. & Olson, E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65, 45-79 (2003). (Pubitemid 38249147)
27. Wang, J., Huang, Y. & Ning, Q. Review on regulation of inwardly rectifying potassium channels. Crit. Rev. Eukaryot. Gene Expr. 21, 303-311 (2011).
28. Dubois, N.C. et al. SIRPA is a specifc cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 29, 1011-1018 (2011).
29. 2+ wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells Dev. 18, 1493-1500 (2009).
30. Baharvand, H., Azarnia, M., Parivar, K. & Ashtiani, S.K. The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J. Mol. Cell Cardiol. 38, 495-503 (2005). (Pubitemid 40331940)
31. De Weer, P., Gadsby, D.C. & Rakowski, R.F. Voltage dependence of the Na-K pump. Annu. Rev. Physiol. 50, 225-241 (1988). (Pubitemid 18088100)
32. Sakai, R., Hagiwara, N., Matsuda, N., Kassanuki, H. & Hosoda, S. Sodium-potassium pump current in rabbit sino-atrial node cells. J. Physiol. (Lond.) 490, 51-62 (1996). (Pubitemid 26020130)
33. Arduini, D. Fetal Cardiac Function (Parthenon Publishing Group, 1995).
34. Schaaf, S. et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS ONE 6, e26397 (2011).
35. Chattergoon, N.N. et al. Thyroid hormone drives fetal cardiomyocyte maturation. FASEB J. 26, 397-408 (2012).
36. McMullen, J.R. et al. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J. Biol. Chem. 279, 4782-4793 (2004). (Pubitemid 38199073)
37. Seif-Naraghi, S.B. et al. Safety and effcacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci. Transl. Med. 5, 173ra125 (2013).
38. Rodriguez, A.G., Han, S.J., Regnier, M. & Sniadecki, N.J. Substrate stiffness increases twitch power of neonatal cardiomyocytes in correlation with changes in myofbril structure and intracellular calcium. Biophys. J. 101, 2455-2464 (2011).
39. Hazeltine, L.B. et al. Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells. Int. J. Cell Biol. 2012, 508294 (2012).
40. Blazeski, A. et al. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog. Biophys. Mol. Biol. 110, 178-195 (2012).
41. Lundy, S.D., Zhu, W.Z., Regnier, M. & Lafamme, M. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. Advance online publication 6 March 2013 (doi:10.1089/scd.2012.0490).
42. Nanthakumar, K. et al. Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fbrillation in humans. Am. J. Physiol. Heart Circ. Physiol. 293, H875-H880 (2007). (Pubitemid 47105154)
43. Witkowski, F.X., Clark, R.B., Larsen, T.S., Melnikov, A. & Giles, W.R. Voltage-sensitive dye recordings of electrophysiological activation in a Langendorff-perfused mouse heart. Can. J. Cardiol. 13, 1077-1082 (1997). (Pubitemid 28004549)
44. Snyders, D.J. & Chaudhary, A. High affnity open channel block by dofetilide of HERG expressed in a human cell line. Mol. Pharmacol. 49, 949-955 (1996). (Pubitemid 26181422)